-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Vanda Pharmaceuticals Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Vanda Pharmaceuticals Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$920K, a 258% decline year-over-year.
- Vanda Pharmaceuticals Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$1.7M, a 129% decline year-over-year.
- Vanda Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2023 was $3.83M, a 23.8% decline from 2022.
- Vanda Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2022 was $5.03M, a 45.5% decline from 2021.
- Vanda Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2021 was $9.21M, a 10.7% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)